{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:52:20Z","timestamp":1758124340393},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.vaccine.2004.07.044","type":"journal-article","created":{"date-parts":[[2004,9,25]],"date-time":"2004-09-25T03:13:32Z","timestamp":1096082012000},"page":"984-995","source":"Crossref","is-referenced-by-count":27,"title":["Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana"],"prefix":"10.1016","volume":"23","author":[{"given":"N.G.","family":"Saravia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H.","family":"Hazb\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Valderrama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Santrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Cort\u00e1zar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.","family":"LeBowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.L.","family":"Travi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.07.044_bib1","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.8451641","article-title":"Th1 and Th2 cell antigen receptors in experimental leishmaniasis","volume":"259","author":"Reiner","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2004.07.044_bib2","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1073\/pnas.93.10.5141","article-title":"Preferential induction of a TH1 inmune response and inhibition of specific IgE antibody formation by plasmid DNA immunization","volume":"93","author":"Raz","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"10.1016\/j.vaccine.2004.07.044_bib3","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1089\/hum.1998.9.13-1899","article-title":"Genetic immunization with glycoprotein 63 cDNA results in a helper T Cell type immune response and protection in a murine model of leishmaniasis","volume":"9","author":"Walker","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2004.07.044_bib4","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/0264-410X(94)90079-5","article-title":"Genetic vaccination against leishmaniasis","volume":"12","author":"Damo","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.07.044_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2307\/3279070","article-title":"Experimental Chagas\u2019 disease protective activity in relation with subcellular fractions of the parasite","volume":"62","author":"Segura","year":"1976","journal-title":"J Parasitol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1550-7408.1977.tb01009.x","article-title":"Antigens of the subcellular fractions of Trypanosoma cruzi II: flagella and membrane fractions","volume":"24","author":"Segura","year":"1977","journal-title":"J Protozol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib7","first-page":"299","article-title":"Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi","volume":"42","author":"Ruiz","year":"1985","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2004.07.044_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/IAI.63.1.122-125.1995","article-title":"Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection","volume":"63","author":"Wrightsman","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.07.044_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/expr.1996.0101","article-title":"Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins in associated with a T helper type Y response","volume":"84","author":"Miller","year":"1996","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib10","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.4049\/jimmunol.158.11.5330","article-title":"Protection of M-mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell but not B cell, function","volume":"158","author":"Miller","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-6851(96)02688-6","article-title":"Stage specific expression of the Leishmania mexicana paraflagellar rod protein PFR-2","volume":"80","author":"Moore","year":"1996","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib12","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1242\/jcs.112.16.2753","article-title":"Genetic dissection of the Leishmania paraflagellar rod, a unique flagellar cytoskeleton structure","volume":"112","author":"Maga","year":"1999","journal-title":"J Cell Sci"},{"key":"10.1016\/j.vaccine.2004.07.044_bib13","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"LaemmLi","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2004.07.044_bib14","series-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.vaccine.2004.07.044_bib15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1550-7408.1989.tb01105.x","article-title":"Flagellar membrane and paraxial rod proteins of Leishmania: characterization employing monoclonal antibodies","volume":"36","author":"Ismach","year":"1989","journal-title":"J Protozool"},{"key":"10.1016\/j.vaccine.2004.07.044_bib16","unstructured":"\u201cHis-Bind\u00ae Kits\u201d Technical Bulletin 054 11\/99B; Novagen Inc."},{"key":"10.1016\/j.vaccine.2004.07.044_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0035-9203(39)90109-4","article-title":"Studies on the culture of Leishmania tropica","volume":"33","author":"Senekjie","year":"1939","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2004.07.044_bib18","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1128\/IAI.70.5.2288-2296.2002","article-title":"Gender is a major determinant of the clinical evolution and immune response of hamsters infected with Leishmania viannia spp.","volume":"70","author":"Travi","year":"2002","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2004.07.044_bib19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2307\/3282713","article-title":"Metastatic capability of Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis in golden hamsters","volume":"77","author":"Martinez","year":"1991","journal-title":"J Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.07.044_bib20","first-page":"367","article-title":"Experimental superimposed infection of the hamster with Leishmania mexicana and L. braziliensis","volume":"39","author":"Zeledon","year":"1982","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2004.07.044_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0167-5699(00)01612-1","article-title":"The prime-boost strategy: exciting prospects for improved vaccination","volume":"21","author":"Ramshaw","year":"2000","journal-title":"Immunol Today"},{"issue":"94","key":"10.1016\/j.vaccine.2004.07.044_bib22","doi-asserted-by":"crossref","first-page":"9378","DOI":"10.1073\/pnas.94.17.9378","article-title":"Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination","volume":"19","author":"Letvin","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2004.07.044_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-3024.1986.tb00831.x","article-title":"Sex-influenced response in the pathogenesis of cutaneous leishmaniasis in mice","volume":"8","author":"Giannini","year":"1986","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1440-1711.1998.00730.x","article-title":"Sex-determined resistance againts Leishmania mexicana is associated with the preferential induction of a Th1-like response and IFN-gamma production by female but no male DBA\/2 mice","volume":"76","author":"Satoskar","year":"1998","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib25","first-page":"1","article-title":"Sex-determined susceptibility and differential IFN-gamma and TNF-alpha mRNA expresi\u00f3n in DBA\/2 mice infected with Leishmania mexicana","volume":"84","author":"Satoskar","year":"1995","journal-title":"Inmunology"},{"key":"10.1016\/j.vaccine.2004.07.044_bib26","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(98)09552-X","article-title":"Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam","volume":"351","author":"Sharifi","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2004.07.044_bib27","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0035-9203(02)90044-1","article-title":"Mechanisms of pathogenesis: differences amongst Leishmania species","volume":"96","author":"Colmenares","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2004.07.044_bib28","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.4049\/jimmunol.150.6.2322","article-title":"Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis","volume":"150","author":"Rachamim","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/IAI.65.1.171-178.1997","article-title":"Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters","volume":"65","author":"McSorley","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.07.044_bib30","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.160.8.3627","article-title":"Cutting edge: CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis","volume":"160","author":"Zimmerman","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1074-7613(00)80256-3","article-title":"Immune activation by bacterial DNA: a new genetic code","volume":"5","author":"Pisetsky","year":"1996","journal-title":"Immunity"},{"issue":"16","key":"10.1016\/j.vaccine.2004.07.044_bib32","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.1073\/pnas.96.16.9305","article-title":"CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cell","volume":"96","author":"Hartmann","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2004.07.044_bib33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/35047207","article-title":"Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2004.07.044_bib34","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1073\/pnas.161293498","article-title":"TLR9 confers responsiveness to bacterial DNA via species specific CpG motif recognition","volume":"98","author":"Bauer","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2004.07.044_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng0695-161","article-title":"Cytokine gene expression in epidermis with biological effects following injection of naked DNA","volume":"10","author":"Hengge","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2004.07.044_bib36","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1084\/jem.186.9.1481","article-title":"Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II restricted viral epitope","volume":"186","author":"Casares","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2004.07.044_bib37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1017\/S0031182000055803","article-title":"Rate of Leishmania induced skin-lesion development in rodents depends on the site of inoculation","volume":"94","author":"Kirkpatrick","year":"1987","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2004.07.044_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-3024.2003.00615.x","article-title":"The site of cutaneous infection influences the clinical and immunological response of hamsters infected with Leishmania panamensis","volume":"25","author":"Osorio","year":"2003","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib39","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/IAI.62.9.3655-3662.1994","article-title":"Site-specific immunity to Leishmania in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response","volume":"62","author":"Nabors","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.07.044_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-3024.1995.tb01000.x","article-title":"The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB\/c \u00d7 C57BL\/6) F1 mice infected with L. major","volume":"17","author":"Nabors","year":"1995","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4049\/jimmunol.158.10.4529","article-title":"Differential dependence on target site tissue for gene gun and intramuscular DNA immunization","volume":"158","author":"Torres","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib42","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1128\/IAI.70.12.6652-6657.2002","article-title":"Marked enhancement of the antigen specific immune response by combining plasmid DNA-based immunization with a Schiff base-forming drug","volume":"70","author":"Charo","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.07.044_bib43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2230.2002.01151.x","article-title":"Imiquimod and the imidazoquinolones: mechanisms of action and therapeutic potential","volume":"27","author":"Stanley","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib44","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.4049\/jimmunol.171.8.4320","article-title":"Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus and HIV-1-specific T cell responses","volume":"171","author":"Lor\u00e9","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2004.07.044_bib45","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0264-410X(01)00081-0","article-title":"A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major","volume":"19","author":"Rafati","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.07.044_bib46","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1128\/IAI.70.6.2828-2836.2002","article-title":"Vaccination with plasmid DNA encoding TSA\/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB\/c mice","volume":"70","author":"Campos-Neto","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.07.044_bib47","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.4049\/jimmunol.166.8.5122","article-title":"The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge","volume":"166","author":"Mendez","year":"2001","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04006280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04006280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T10:47:33Z","timestamp":1682765253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04006280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0264410X04006280"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.07.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}